{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:18:32Z","timestamp":1648556312274},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PPA"],"DOI":"10.2147\/ppa.s23241","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T15:39:44Z","timestamp":1332517184000},"page":"239","source":"Crossref","is-referenced-by-count":0,"title":["Update on treatment of follicular non-Hodgkin’s lymphoma: focus on potential of bortezomib"],"prefix":"10.2147","author":[{"given":"Anne","family":"Beaven","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Brander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,3]]},"container-title":["Patient Preference and Adherence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=12369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:11:42Z","timestamp":1477865502000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/update-on-treatment-of-follicular-non-hodgkinrsquos-lymphoma-focus-on--peer-reviewed-article-PPA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ppa.s23241","relation":{},"ISSN":["1177-889X"],"issn-type":[{"value":"1177-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}